Cite
HARVARD Citation
Shockley, A. et al. (2022). Safety and tolerability of lenalidomide maintenance dosing in patients with multiple myeloma post-autologous stem cell transplant. Journal of oncology pharmacy practice. pp. 1613-1616. [Online].